13F-HR - HORIZON FINANCIAL SERVICES, LLC (0001674020) (Filer)
Institutional holdings report (13F-HR) filed by HORIZON FINANCIAL SERVICES, LLC.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Institutional holdings report (13F-HR) filed by HORIZON FINANCIAL SERVICES, LLC.
Institutional holdings report (13F-HR) filed by Rainwater Charitable Foundation.
Institutional holdings report (13F-HR) filed by PRAIRIE ADVISORY, LLC.
Institutional holdings report (13F-HR) filed by JGP Global Gestao de Recursos Ltda..
Institutional holdings report (13F-HR) filed by FOUNDERS CAPITAL MANAGEMENT, LLC.
Institutional holdings report (13F-HR) filed by Positano Wealth Management Ltd.
Institutional holdings report (13F-HR) filed by Lifestyle Asset Management, Inc..
Institutional holdings report (13F-HR) filed by ABC ARBITRAGE SA.
Institutional holdings report (13F-HR) filed by Amicus Financial Advisors, LLC.
Institutional holdings report (13F-HR) filed by QP WEALTH MANAGEMENT, LLC.
Institutional holdings report (13F-HR) filed by Global Wealth Management, LLC.
Peoples Bancorp of North Carolina reported second quarter 2026 net earnings of $5.2 million, or $0.98 per share, reflecting increased net interest income. The results indicate cont…
SES AI Corp received a notice from the NYSE regarding non-compliance with continued listing standards due to a low stock price. The company plans to cure the deficiency and expects…
Institutional holdings report (13F-HR) filed by THOR INVESTMENT MANAGEMENT INC /OH/ /ADV.
Institutional holdings report (13F-HR) filed by Koesten, Hirschmann & Crabtree, INC..
Institutional holdings report (13F-HR) filed by ASR Vermogensbeheer N.V..
Personalis agreed to be acquired by Tempus for $1.5 billion, combining Tempus' commercial platform with Personalis' residual disease technology to advance cancer monitoring.
Hancock Whitney Corporation has received regulatory clearance and shareholder approval to acquire OFB Bancshares, Inc., with the deal expected to close by August 2026.
Institutional holdings report (13F-HR) filed by Ardent Capital Management, Inc..
Tempus agreed to acquire Personalis for $1.5 billion, combining Personalis's MRD technology with Tempus's AI platform to expand cancer monitoring capabilities. The deal targets the…